ExpreS2ion rearranges its event schedule due to Coronavirus restrictions
ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") is rearranging its recently communicated event schedule due to events changes as a results of COVID-19-related travel restrictions. The company’s main priority during this time is to progress rapidly with the ongoing EU Horizon 2020-funded COVID-19 vaccine development project together with the rest of the consortium members.ExpreS[2]ion’s CEO Bent U. Frandsen will present the company for the Aktiedagen event on March 16 in Stockholm virtually, which means you can view it later today at ExpreS[2]ion’s